An integrative naturopathic oncology approach in metastatic malignant melanoma: two case reports
-
By
-
Sara Izadi-Najafabadi
-
Sydney Moffatt
-
Mackenzie Neufeld
-
Gurdev Parmar
-
July 10, 2026
-
Clinical Scorecard: A Comprehensive Naturopathic Oncology Strategy for Metastatic Malignant Melanoma: Two Case Studies
At a Glance
| Category | Detail |
|---|
| Condition | Malignant Melanoma |
| Key Mechanisms | Integrative naturopathic oncology approaches including hyperthermia, intravenous pharmacologic ascorbic acid, mistletoe therapy, and repurposed drugs. |
| Target Population | Patients with metastatic malignant melanoma. |
| Care Setting | Integrated Health Clinic (IHC) with a focus on integrative naturopathic protocols. |
Key Highlights
- Case 1: Prolonged remission after multiple recurrences treated with integrative naturopathic therapies.
- Case 2: Complete remission achieved with naturopathic therapies after conventional options were exhausted.
- Both cases demonstrate regression of metastatic lesions with no detectable disease on imaging.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of malignant melanoma is stage-dependent and includes assessment of Breslow depth and presence of metastasis.
Management
- Standard treatments include surgical resection, radiotherapy, immune checkpoint inhibitors, and targeted therapies.
Monitoring & Follow-up
- Follow-up imaging is essential to assess disease status post-treatment.
Risks
- Risk factors include excessive UV exposure, fair skin, genetic susceptibility, and immunosuppression.
Patient & Prescribing Data
Women with metastatic malignant melanoma.
Patients pursued naturopathic therapies alongside surgery and/or radiotherapy, leading to significant clinical outcomes.
Clinical Best Practices
- Incorporate integrative oncology approaches alongside conventional treatments for advanced melanoma.
- Monitor quality of life and survivorship needs in melanoma survivors.
Related Resources & Content
